Iron loading increases cholesterol accumulation and macrophage scavenger receptor I expression in THP-1 mononuclear phagocytes

Metabolism: Clinical and Experimental

Volumn 54, Issue 4, 2005, Pages 453-459

  Kraml, Pavel J ^a   Klein, Richard L ^b,c   Huang, Yan ^b,c   Nareika, Alena ^b   Lopes Virella, Maria F ^b,c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CHOLESTEROL ESTER; IODINE 125; IRON; LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR BI;

ARTICLE; ATHEROGENESIS; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; MONONUCLEAR PHAGOCYTE; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM;

EID: 15744362815     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.10.012     Document Type: Article

References (27)

1. J.L. Sullivan Iron and the sex difference in heart disease risk Lancet 1 1981 1293 1294
2. B. de Valk, and J.J.M. Marx Iron, atherosclerosis, and ischemic heart disease Arch. Intern. Med. 159 1999 1542 1548
3. J.L. Sullivan The iron paradigm of ischemic heart disease Am. Heart J. 117 1989 1177 1188
4. M.J. Burt, J.W. Halliday, and L.W. Powell Iron and coronary heart disease BMJ 307 1993 575 576
5. R.B. Lauffer Iron stores and the international variation in mortality from coronary artery disease Med. Hypotheses 35 1991 96 102
6. T.-P. Toumainen, K. Punnonen, K. Nyyssönen, and J.T. Salonen Association between body iron stores and the risk of acute myocardial infarction in men Circulation 97 1998 1461 1466
7. S. Kiechl, J. Willet, G. Egger, W. Poewe, and F. Oberhollenzer Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study Circulation 96 1997 3300 3307
8. J.T. Salonen, K. Nyyssönen, H. Korpela, J. Tuomilehto, R. Seppänen, and R. Salonen High stored iron levels are associated with excess risk of myocardial infarction in eastern Finish men Circulation 86 1992 803 811
9. J.A. Berliner, and J.W. Heinecke The role of oxidized lipoproteins in atherogenesis Free Radic. Biol. Med. 20 1996 707 727
10. D. Steinberg Low density lipoprotein oxidation and its pathobiological significance J. Biol. Chem. 272 1997 20963 20966
11. A.C. Li, and C.K. Glass The macrophage foam cell as a target for therapeutic intervention Nat. Med. 8 2002 1235 1242
12. S. Yla-Herttuala Macrophages and oxidized low density lipoproteins in the pathogenesis of atherosclerosis Ann. Med. 23 1991 561 567
13. M.A. Connelly, S.M. Kein, S. Azhar, N.A. Abumrad, and D.L. Williams Comparison of class B scavenger receptors, CD36, and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake J. Biol. Chem. 274 1999 41 47
14. A.J. Jenkins, R.L. Klein, C.N. Chassereau, K.I. Hermayer, and M.F. Lopes-Virela LDL from patients with well-controlled IDDM is not susceptible to in vitro oxidation Diabetes 45 1996 762 776
15. A. Hara, and N.S. Radin Lipid extraction of tissues with a low toxicity solvent Anal. Biochem. 90 1978 420 426
16. M.A.K. Markwell, S.M. Haas, L.L. Bieber, and N.E. Tolbert A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples Anal. Biochem. 87 1978 206 211
17. M.F. Lopes-Virella, R.L. Klein, and H.C. Stevenson LDL metabolism in human macrophages stimulated with microbial or microbial-related products Arteriosclerosis 7 1987 176 184
18. R.L. Klein, H.J. Wohltman, and M.F. Lopes-Virella Influence of glycemic control on interaction of very low and low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients by human monocyte-derived macrophages Diabetes 41 1992 1301 1307
19. D.S. Abdalla, L.F. Costa-Rosa, H.P. Monteiro, A. Campa, and R. Curi Human macrophage metabolism of low density lipoprotein oxidized by stimulated neutrophils and ferritin Atherosclerosis 107 1994 157 163
20. P.A. Dawson, S.L. Hofmann, D.R. van der Westhuyzen, T.C. Sudhof, M.S. Brown, and J.L. Goldstein Sterol-dependent repression of low density lipoprotein receptor promoter mediated by 16-base pair sequence adjacent to binding site for transcription factor Sp1 J. Biol. Chem. 263 1988 3372 3379
21. G. Hoppe, J. O'Neil, and H.F. Hoff Inactivation of lysosomal proteases by oxidized low density lipoprotein is partially responsible for its poor degradation by mouse peritoneal macrophages J. Clin. Invest. 94 1994 1506
22. X.M. Yuan, W. Li, W.L. Anders, A.G. Olsson, and U.T. Brunk Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis Atherosclerosis 124 1996 61 73
23. B. Fuhrmann, J. Oiknine, and M. Aviram Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties Atherosclerosis 111 1994 65 78
24. Y. Gazitt, S.V. Reddy, O. Alcantara, J. Yang, and D.H. Boldt A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate J. Cell. Physiol. 187 2001 124 135
25. S.J. De Kimpe, E.E. Anggard, and M.J. Carrier Reactive oxygen species regulate macrophage scavenger receptor type I, but not type II, in the human monocytic cell line THP-I Mol. Pharmacol. 53 1998 1076 1082
26. A.L. Health, C.M. Skeaff, and S.M. O'Brien Can dietary treatment of non-anemic iron deficiency improve iron status? J. Am. Coll. Nutr. 20 2001 477 484
27. J.M. Liu, S.E. Hankinson, and M.J. Stampfer Body iron stores and their determinants in healthy postmenopausal US women Am. J. Clin. Nutr. 78 2003 1160 1167